Substance use may confound the study of brain structure in schizophrenia. We used voxel-based morphometry (VBM) to examine whether differences in regional gray matter volumes exist between schizophrenia patients with (n = 92) and without (n = 66) clinically significant cannabis and/or alcohol use histories compared to 88 healthy control subjects. Relative to controls, patients with schizophrenia had reduced gray matter volume in the bilateral precentral gyrus, right medial frontal cortex, right visual cortex, right occipital pole, right thalamus, bilateral amygdala, and bilateral cerebellum regardless of substance use history. Within these regions, we found no volume differences between patients with schizophrenia and a history of cannabis and/or alcohol compared to patients with schizophrenia without a clinically significant substance use history. Our data support the idea that a clinically meaningful history of alcohol or cannabis use does not significantly compound the gray matter deficits associated with schizophrenia.
Introduction
Comorbid substance use disorders are highly prevalent in individuals with schizophrenia spectrum psychotic disorders and are associated with increased mortality, decreased treatment compliance, and worse outcomes (Ascher-Svanum et al., 2006; Hjorthøj et al., 2015; Moore et al., 2012; Nesvåg et al., 2015; Volkow, 2009) . It has been well documented that in schizophrenia there are gray matter deficits in multiple regions including the medial frontal gyrus, temporal cortex, insula, cingulate cortex, thalamus, hippocampus, and amygdala (Ellison-Wright and Bullmore, 2010; Shepherd et al., 2012; Van Erp et al., 2016) . Substance use disorder comorbidity may be an important confound in investigations of the neurobiological basis of schizophrenia, since both illnesses are independently associated with changes in brain structure (Thoma and Daum, 2013; Van Haren et al., 2013; Weinberger and Radulescu, 2016) .
Cannabis and alcohol are among the most frequently misused substances in schizophrenia (Nesvåg et al., 2015) . Meta-analyses have revealed that many of the regions implicated in the pathophysiology of schizophrenia also show volume deficits in individuals with alcohol and cannabis use disorders who do not have psychosis. In non-psychotic individuals with alcohol use disorder, gray matter reductions have been identified in the dorsolateral prefrontal cortex, anterior cingulate cortex, temporal gyrus, insula, precentral gyrus, thalamus, hippocampus, and striatum (Xiao et al., 2015) . Additionally, multiple previous studies have shown that greater atrophy in these regions is significantly associated with the severity of alcohol consumption (Yang et al., 2016) . The effects of cannabis use on brain structure are more variable than those observed with alcohol use disorders, but increased severity of cannabis use is associated with greater structural changes in the hippocampus, prefrontal cortex, amygdala, insula, cerebellum, and striatum (Lorenzetti et al., 2016) . Decreased hippocampal volume is the most consistently found structural alteration in cannabis users relative to non-users, with a medium effect size (Rocchetti et al., 2013) . Current evidence suggests that alcohol and cannabis use disorders produce partially overlapping effects on the brain and the extent of changes in brain structure depends on the severity of use in nonpsychotic individuals.
The extant literature comparing schizophrenia patients with and without a history of substance use has thus far not resolved whether substance use serves as a confound in studies of brain volume in schizophrenia. Some studies have found greater volume deficits due to substance use in both overall gray matter and specific brain regions, including the amygdala, hippocampus, cerebellum and cingulate cortex, while others have found no evidence for such differences (Malchow et al., 2013a; Thoma and Daum, 2013) . Critically, only two previous studies have used whole brain, voxel based morphometry (VBM) to examine the effect of substance use on brain structure in https://doi.org/10.1016/j.pscychresns.2018.08.002 Received 12 January 2018; Received in revised form 14 May 2018; Accepted 2 August 2018
